Grown Rogue International (GRUSF) Amortizatization of Intangibles (2018 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Amortizatization of Intangibles of $42210.0 in Q1 2026, down 100.0% quarter-over-quarter from $812.2 billion in Q4 2025, and down 80.83% on a YoY basis from $220133.0 in Q1 2025.
Grown Rogue International (GRUSF) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Grown Rogue International's Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $42210.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 80.83% year-over-year to $42210.0; the TTM figure through Mar 2026 stood at $588.4 billion (up 125.55% YoY), while the FY2024 annual figure was -$2.0 million, down 1043.47% from the prior year.
- Amortizatization of Intangibles was $42210.0 for Q1 2026 at Grown Rogue International, down from $812.2 billion in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $812.2 billion in Q4 2025 to a low of -$1531.5 billion in Q4 2024.
- Historically, Amortizatization of Intangibles has averaged -$114.3 billion across 5 years, with a median of $137794.0 in 2022.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles soared 153.03% in 2025, then tumbled 80.83% in 2026.
- A 5-year view of Amortizatization of Intangibles shows it stood at $137794.0 in 2022, then surged by 526.02% to $862624.0 in 2023, then sank by 177545492.15% to -$1531.5 billion in 2024, then jumped by 153.03% to $812.2 billion in 2025, then sank by 100.0% to $42210.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $42210.0 (Q1 2026), $812.2 billion (Q4 2025), and -$223.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 42,210.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42,210.00 |
| Mar 31, 2026 | 42,210.00 |
| Dec 31, 2025 | 812.21 Bn |
| Dec 31, 2025 | 812.21 Bn |
| Sep 30, 2025 | -223.82 Bn |
| Sep 30, 2025 | -223.82 Bn |
| Jun 30, 2025 | -368,258.00 |
| Jun 30, 2025 | -368,258.00 |
| Mar 31, 2025 | 220,133.00 |
| Mar 31, 2025 | 220,133.00 |
| Dec 31, 2024 | -1,531.55 Bn |
| Dec 31, 2024 | -1,531.55 Bn |
| Sep 30, 2024 | -771.48 Bn |
| Sep 30, 2024 | -771.48 Bn |
| Jun 30, 2024 | -276,666.51 |
| Jun 30, 2024 | -276,666.51 |
| Mar 31, 2024 | 381,663.00 |
| Mar 31, 2024 | 381,663.00 |
| Oct 31, 2023 | 862,624.00 |
| Oct 31, 2023 | 862,624.00 |